Early detection and appropriate treatment of this high-risk population ... reported in this study include not only the initial acute DVT or PE event but also the chronic longer term consequences ...

The filter may be in place temporarily or permanently. Other options for DVT include percutaneous mechanical thrombectomy or catheter directed thrombolysis. Treatment for a PE can include blood ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...

Using risk assessment and nurse education in the High ED/Admission Risk Therapy (HEART) protocol reduced ED visits by 18% ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

Is the incidence of acute otitis media increasing or decreasing ... events in patients with nephrotic syndrome vary, with deep venous thrombosis occurring in approximately 15% of patients ...

AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

Alice John, an 88-year-old Indian woman visiting Brampton, Ontario, on a super visa, faced a medical emergency requiring ...

Discover why difficult breathing might indicate heart disease, lung conditions, anxiety disorders, or blood problems, and ...

Amgen today announced that the global Phase 3 DeLLphi-304 clinical trial evaluating IMDELLTRA® (tarlatamab-dlle) as a treatment for patients with small cell lung cancer (SCLC) who progressed on or ...

Six little words that obliterated our dreams.” Sarah had experienced a missed miscarriage, also known as a silent or delayed ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...